China NMPA Accelerates Market Access For Imported Medicines

 
• By Xu Hu
  
Shortened path
The NMPA shortens time for certain imported medicines to enter the China market. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from China